Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-5 of 5
Keywords: Pembrolizumab
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer
Available to Purchase
Journal:
Chemotherapy
Chemotherapy (2025)
Published Online: 13 March 2025
...Li Wang; Kai Yang; Xinxin Xie; Hailiang Wei; Pengli Wang; Shaohui Wang Introduction: This study aims to evaluate the efficacy and safety of cryoablation combined with pembrolizumab treatment versus cryoablation alone in patients with advanced non-small cell lung cancer (NSCLC). Methods...
Journal Articles
Meta-Analysis of the Efficacy and Safety of Pembrolizumab in the Treatment of Advanced Gastric Cancer and Gastroesophageal Junction Cancer
Available to PurchaseJingyun Yang, Weisheng Luo, Xiaocong Ma, Yinhang Cui, Jiacheng Xie, Chengzhen Pan, Ziyao Chen, Shuang Yang
Journal:
Chemotherapy
Chemotherapy (2025) 70 (1): 37–51.
Published Online: 17 July 2024
...Jingyun Yang; Weisheng Luo; Xiaocong Ma; Yinhang Cui; Jiacheng Xie; Chengzhen Pan; Ziyao Chen; Shuang Yang Introduction: Pembrolizumab has been approved for the first-line treatment of patients with advanced gastric cancer (GC) and gastroesophageal junction (GEJ) cancer. However, the results...
Journal Articles
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report
Available to PurchaseMarianna Gentilini, Beatrice Casadei, Alice Morigi, Ginevra Lolli, Marco Ferrari, Matteo Carella, Lisa Argnani, Pier Luigi Zinzani
Journal:
Chemotherapy
Chemotherapy (2023) 68 (4): 219–221.
Published Online: 13 June 2023
... of a relapsed/refractory Hodgkin lymphoma with a critical vegetative mass at the level of the trachea successfully treated with pembrolizumab. [email protected] 25 07 2022 8 09 2022 13 06 2023 © 2023 S. Karger AG, Basel Copyright / Drug Dosage / Disclaimer Copyright: All...
Journal Articles
On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment
Available to Purchase
Journal:
Chemotherapy
Chemotherapy (2019) 64 (2): 62–80.
Published Online: 31 October 2019
..., instructions or products referred to in the content or advertisements. 2019 Metastatic melanoma Non-small cell lung cancer Nivolumab Pembrolizumab Atezolizumab The immune checkpoint (ICK) therapy is an emerging approach to oncological treatment, which is increasingly used for a variety...
Journal Articles
A Complete Pathological Response to Pembrolizumab following ex vivo Liver Resection in a Patient with Colorectal Liver Metastases
Available to PurchaseMaria Baimas-George, Erin Baker, Michal Kamionek, J. Stuart Salmon, Amit Sastry, David Levi, Dionisios Vrochides
Journal:
Chemotherapy
Chemotherapy (2018) 63 (2): 90–94.
Published Online: 24 May 2018
..., a pathologically complete response (PCR) to chemotherapy for colorectal liver metastases is still rare, and its significance is not fully understood. In this case report, we describe a patient who achieved PCR after neoadjuvant immunotherapy with pembrolizumab and a left hepatectomy using an ex vivo resection...